List of Tables
Table 1. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of HEPtune® Technology
Table 3. Key Players of Intravail® Technology
Table 4. Key Players of RapidMist™
Table 5. Key Players of TheraKine Technology
Table 6. Key Players of Arestat™ Technology
Table 7. Key Players of DelSiTech™ Silica Matrix
Table 8. Key Players of ImSus® Technology
Table 9. Key Players of PLEX™ Technology
Table 10. Key Players of ENHANZE® Technology
Table 11. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 12. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 13. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Region (2019-2024) & (US$ Million)
Table 14. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Region (2019-2024)
Table 15. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 16. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Region (2025-2030)
Table 17. Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Trends
Table 18. Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Drivers
Table 19. Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Challenges
Table 20. Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Restraints
Table 21. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue by Players (2019-2024) & (US$ Million)
Table 22. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Share by Players (2019-2024)
Table 23. Global Top Technologies for Delivery of Proteins, Antibodies and Nucleic Acids by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids as of 2023)
Table 24. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Industry Ranking 2022 VS 2023 VS 2024
Table 25. Global 5 Largest Players Market Share by Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (CR5 and HHI) & (2019-2024)
Table 26. Global Key Players of Technologies for Delivery of Proteins, Antibodies and Nucleic Acids, Headquarters and Area Served
Table 27. Global Key Players of Technologies for Delivery of Proteins, Antibodies and Nucleic Acids, Product and Application
Table 28. Global Key Players of Technologies for Delivery of Proteins, Antibodies and Nucleic Acids, Product and Application
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2019-2024) & (US$ Million)
Table 31. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share by Type (2019-2024)
Table 32. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 33. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share by Type (2025-2030)
Table 34. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2019-2024) & (US$ Million)
Table 35. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Share by Application (2019-2024)
Table 36. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 37. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Share by Application (2025-2030)
Table 38. North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2019-2024) & (US$ Million)
Table 39. North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2025-2030) & (US$ Million)
Table 40. North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2019-2024) & (US$ Million)
Table 41. North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2025-2030) & (US$ Million)
Table 42. North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Country (2019-2024) & (US$ Million)
Table 44. North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Country (2025-2030) & (US$ Million)
Table 45. Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2019-2024) & (US$ Million)
Table 46. Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2025-2030) & (US$ Million)
Table 47. Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2019-2024) & (US$ Million)
Table 48. Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2025-2030) & (US$ Million)
Table 49. Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 50. Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Country (2019-2024) & (US$ Million)
Table 51. Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Country (2025-2030) & (US$ Million)
Table 52. China Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2019-2024) & (US$ Million)
Table 53. China Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2025-2030) & (US$ Million)
Table 54. China Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2019-2024) & (US$ Million)
Table 55. China Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2025-2030) & (US$ Million)
Table 56. Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2019-2024) & (US$ Million)
Table 57. Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2025-2030) & (US$ Million)
Table 58. Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2019-2024) & (US$ Million)
Table 59. Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2025-2030) & (US$ Million)
Table 60. Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 61. Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Region (2019-2024) & (US$ Million)
Table 62. Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Region (2025-2030) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2019-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2025-2030) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2019-2024) & (US$ Million)
Table 66. Middle East, Africa, and Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2025-2030) & (US$ Million)
Table 67. Middle East, Africa, and Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 68. Middle East, Africa, and Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Country (2019-2024) & (US$ Million)
Table 69. Middle East, Africa, and Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Country (2025-2030) & (US$ Million)
Table 70. Aphios Company Details
Table 71. Aphios Business Overview
Table 72. Aphios Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product
Table 73. Aphios Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2019-2024) & (US$ Million)
Table 74. Aphios Recent Developments
Table 75. Arbutus Biopharma Company Details
Table 76. Arbutus Biopharma Business Overview
Table 77. Arbutus Biopharma Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product
Table 78. Arbutus Biopharma Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2019-2024) & (US$ Million)
Table 79. Arbutus Biopharma Recent Developments
Table 80. Camurus Company Details
Table 81. Camurus Business Overview
Table 82. Camurus Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product
Table 83. Camurus Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2019-2024) & (US$ Million)
Table 84. Camurus Recent Developments
Table 85. ConjuChem Company Details
Table 86. ConjuChem Business Overview
Table 87. ConjuChem Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product
Table 88. ConjuChem Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2019-2024) & (US$ Million)
Table 89. ConjuChem Recent Developments
Table 90. InnoCore Pharmaceuticals Company Details
Table 91. InnoCore Pharmaceuticals Business Overview
Table 92. InnoCore Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product
Table 93. InnoCore Pharmaceuticals Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2019-2024) & (US$ Million)
Table 94. InnoCore Pharmaceuticals Recent Developments
Table 95. LATITUDE Pharmaceuticals Company Details
Table 96. LATITUDE Pharmaceuticals Business Overview
Table 97. LATITUDE Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product
Table 98. LATITUDE Pharmaceuticals Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2019-2024) & (US$ Million)
Table 99. LATITUDE Pharmaceuticals Recent Developments
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Type: 2023 VS 2030
Figure 3. HEPtune® Technology Features
Figure 4. Intravail® Technology Features
Figure 5. RapidMist™ Features
Figure 6. TheraKine Technology Features
Figure 7. Arestat™ Technology Features
Figure 8. DelSiTech™ Silica Matrix Features
Figure 9. ImSus® Technology Features
Figure 10. PLEX™ Technology Features
Figure 11. ENHANZE® Technology Features
Figure 12. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 13. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Application: 2023 VS 2030
Figure 14. Delivery of Protein Case Studies
Figure 15. Delivery of Nucleic Acids Case Studies
Figure 16. Delivery Antibody Case Studies
Figure 17. Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Report Years Considered
Figure 18. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 19. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 20. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Region: 2023 VS 2030
Figure 21. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Players in 2023
Figure 22. Global Top Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids as of 2023)
Figure 23. The Top 10 and 5 Players Market Share by Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue in 2023
Figure 24. North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Type (2019-2030)
Figure 26. North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Application (2019-2030)
Figure 27. North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Country (2019-2030)
Figure 28. United States Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Canada Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY (2019-2030) & (US$ Million)
Figure 31. Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Type (2019-2030)
Figure 32. Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Application (2019-2030)
Figure 33. Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Country (2019-2030)
Figure 34. Germany Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. France Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. U.K. Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Italy Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Russia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Nordic Countries Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. China Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY (2019-2030) & (US$ Million)
Figure 41. China Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Type (2019-2030)
Figure 42. China Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Application (2019-2030)
Figure 43. Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY (2019-2030) & (US$ Million)
Figure 44. Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Type (2019-2030)
Figure 45. Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Application (2019-2030)
Figure 46. Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Region (2019-2030)
Figure 47. Japan Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. South Korea Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. China Taiwan Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Southeast Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. India Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Australia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Middle East, Africa, and Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY (2019-2030) & (US$ Million)
Figure 54. Middle East, Africa, and Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Type (2019-2030)
Figure 55. Middle East, Africa, and Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Application (2019-2030)
Figure 56. Middle East, Africa, and Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Country (2019-2030)
Figure 57. Brazil Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 58. Mexico Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 59. Turkey Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 60. Saudi Arabia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 61. Israel Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 62. GCC Countries Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 63. Aphios Revenue Growth Rate in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2019-2024)
Figure 64. Arbutus Biopharma Revenue Growth Rate in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2019-2024)
Figure 65. Camurus Revenue Growth Rate in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2019-2024)
Figure 66. ConjuChem Revenue Growth Rate in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2019-2024)
Figure 67. InnoCore Pharmaceuticals Revenue Growth Rate in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2019-2024)
Figure 68. LATITUDE Pharmaceuticals Revenue Growth Rate in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2019-2024)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
